Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00255879 · ClinicalTrials.gov registry record · Phase 1
Movement Disorders Caused by Antipsychotic Drugs in Older Patients
A Phase 1 study of Dyskinesia, Drug-Induced, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT00255879: Completed Phase 1 study of Dyskinesia, Drug-Induced, sponsored by University of California, San Diego.
NCT00255879 is a Phase 1 study of Dyskinesia, Drug-Induced that has completed, run by University of California, San Diego. The registered enrollment target is 250 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (317% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00255879, a Phase 1 study of Dyskinesia, Drug-Induced, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the risk of experiencing tardive dyskinesia and other movement disturbances associated with three atypical antipsychotic drugs among middle-aged and elderly psychiatric patients.
Conditions Studied
Interventions
- DRUG Risperidone
- DRUG Olanzapine
- DRUG Quetiapine
Study Locations (1)
California
- University of California, San Diego Division of Geriatric Psychiatry - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 1999-01 |
| Est. Completion | 2004-08 |
| Phase | Phase 1 |
What the finished NCT00255879 record still lists
NCT00255879 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (317% higher).
The record links to 1 condition, with Dyskinesia, Drug-Induced appearing as the primary indexed condition, and to 3 interventions - of which Risperidone is the first listed.
NCT00255879 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00255879 about?
NCT00255879 is a clinical study titled "Movement Disorders Caused by Antipsychotic Drugs in Older Patients". This study will assess the risk of experiencing tardive dyskinesia and other movement disturbances associated with three atypical antipsychotic drugs among middle-aged and elderly psychiatric patients.
What is the current status of trial NCT00255879?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 250 participants. The study started on 1999-01. Estimated completion is 2004-08.
What conditions does trial NCT00255879 study?
This clinical trial studies the following conditions: Dyskinesia, Drug-Induced.
What interventions are being tested in trial NCT00255879?
The interventions under investigation include: Risperidone (DRUG), Olanzapine (DRUG), Quetiapine (DRUG).
Who is sponsoring clinical trial NCT00255879?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00255879 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00255879's enrollment target sits among peer trials
250 173rd of 2000 higher than 1,816 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia